StreetInsider.com News Articles

Tenet Healthcare (THC) PT Raised to $307 at Guggenheim

Fri, 16 Oct 2026 07:52:41 -0400

(Updated - October 16, 2026 7:52 AM EDT)

Guggenheim analyst Jason Cassorla raised the price target on Tenet Healthcare (NYSE: THC) to $307.00 (from $283.00) while maintaining a Buy rating.

The analyst commented: "Despite the evolving backdrop, we anticipate THC will stick to its working playbook, with solid 3Q26 execution powered by continued momentum in its high-acuity and cost efficiency strategies. For the quarter, we expect investor focus to remain on the pace/durability of Hospital segment earnings growth, as high-acuity throughput and efficiency gains go head-to-head with conservative HIX headwind assumptions and the broader affordability narrative. At USPI, beyond the usual suspects

Tenet Healthcare (THC) PT Raised to $307 at Guggenheim

Fri, 16 Oct 2026 07:52:41 -0400

(Updated - October 16, 2026 7:52 AM EDT)

Guggenheim analyst Jason Cassorla raised the price target on Tenet Healthcare (NYSE: THC) to $307.00 (from $283.00) while maintaining a Buy rating.

Tenet Healthcare (THC) Reiterated at Overweight by Cantor Fitzgerald

Tue, 06 Oct 2026 07:35:31 -0400

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $270.00 price target on Tenet Healthcare (NYSE: THC).

The analyst commented, "Labor is stable, with acute the clearest support. Acute openings were stable at 8.4% vs. 8.5% and 2/3 bonus metrics improved, which suggests THC is adequately staffed. ASC/outpatient openings rose to 0.52 vs. 0.41 per facility (0.60 in September), but off a very low base that we do not view as pressure, and 2/3 bonus metrics improved. Physician openings edged up to 225 vs. 218, and bonus usage has risen for a 3rd consecutive quarter, which is something we continually

FTC warns 24 healthcare companies over pricing transparency

Mon, 05 Oct 2026 12:21:16 -0400

Federal Trade Commission Chairman Andrew Ferguson sent letters to 24 large healthcare services companies, warning them of their legal obligation to provide patients with timely, accurate, and complete pricing information, according to a statement from the agency.

The letters state that failing to provide transparent price information may constitute an unfair or deceptive practice under Section 5 of the FTC Act, particularly for routine and non-emergency medical care scheduled in advance.

The FTC noted that compliance with Centers for Medicare & Medicaid Services price transparency rules does not exempt healthcare facilities from FTC Act obligations. The agency stated that CMS rules do

FTC warns 24 healthcare companies over pricing transparency

Mon, 05 Oct 2026 12:21:16 -0400

FTC warns 24 healthcare companies over pricing transparency

Mon, 05 Oct 2026 12:21:16 -0400

Tenet to Report Its Third Quarter 2026 Results on October 29

Fri, 02 Oct 2026 08:00:00 -0400

DALLAS--(BUSINESS WIRE)-- Tenet Healthcare Corporation (NYSE: THC) will release its third quarter 2026 results before the market opens on Thursday, October 29, 2026, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time).

A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory

Tenet to Report Its Third Quarter 2026 Results on October 29

Fri, 02 Oct 2026 08:00:00 -0400

A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors.

About Tenet Healthcare

Tenet Healthcare (THC) Reiterated at Overweight by Cantor Fitzgerald - 2027 is Most Visible

Fri, 02 Oct 2026 07:07:37 -0400

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $270.00 price target on Tenet Healthcare (NYSE: THC).

The analyst commented, "We prefer THC as the name where 2027 is most visible. Its main headwinds are already sized ($92M of DPP one-timers & a $290M CommonSpirit/Conifer headwind). Survey outpatient volumes (0.7%) are in line with consensus (0.8%), but consensus expects USPI cases to step up 200bps from (1.2%) in 2Q26, which the survey does not support. On inpatient, respondents' 2.5% outlook is 100bps above THC's 1.5% guidance midpoint, and we view THC's lighter guide as an advantage."

For an analyst ratings summary

TD Cowen says AI opportunities are real for hospitals

Wed, 30 Sep 2026 09:08:16 -0400

TD Cowen analyst Ryan Langston commented: "We believe investors are not contemplating significant AI benefits to hospitals. We see AI uptake providing a base case ~240bps acute margin opportunity over time. The "holy grail" of using AI to improve clinical labor workflows adds ~160bps margin for every 5% efficiency change. Reimbursement mechanics may compress rate growth and pressure LT benefit durability, making first mover advantage key. Companies with well-defined AI strategies and size/scale to use first-mover advantage like HCA, THC, and UHS should be well positioned."

TD Cowen says AI opportunities are real for hospitals

Wed, 30 Sep 2026 09:08:16 -0400

TD Cowen says AI opportunities are real for hospitals

Wed, 30 Sep 2026 09:08:16 -0400

Raymond James Assumes Tenet Healthcare (THC) at Outperform

Mon, 28 Sep 2026 07:17:39 -0400

Raymond James analyst Andrew Cooper assumes coverage on Tenet Healthcare (NYSE: THC) with a Outperform rating and a price target of $285.00.

For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.

Shares of Tenet Healthcare closed at $259.71 yesterday.

BMO Capital Starts Tenet Healthcare (THC) at Market Perform

Tue, 22 Sep 2026 16:47:56 -0400

(Updated - September 22, 2026 4:47 PM EDT)

BMO Capital analyst Sean Dodge initiates coverage on Tenet Healthcare (NYSE: THC) with a Market Perform rating and a price target of $265.00.

The analyst comments "THC's expanding Ambulatory (i.e., ASC) business increasingly leverages it to an endmarket with more favorable structural LT tailwinds and higher margins/returns while accelerating investment in its hospitals is driving organic growth that is helping offset stiff macro headwinds. Management has also stepped up work on more complex operational initiatives and increased tech investments/deployments, the combination of which should further optimize its base and drive incremental efficiencies. Tenet's recent

BMO Capital Starts Tenet Healthcare (THC) at Market Perform

Tue, 22 Sep 2026 16:47:56 -0400

(Updated - September 22, 2026 4:47 PM EDT)

BMO Capital analyst Sean Dodge initiates coverage on Tenet Healthcare (NYSE: THC) with a Market Perform rating and a price target of $265.00.

Tenet Healthcare issues $2B in senior notes to refinance debt

Tue, 22 Sep 2026 16:07:54 -0400

Tenet Healthcare Corporation (NYSE: THC) issued $2 billion in aggregate principal amount of 6.250% senior notes due 2034 on September 22, 2026, according to a press release statement.

The notes were issued under an indenture dated November 6, 2001, between the company and The Bank of New York Mellon Trust Company, N.A., as successor trustee, as supplemented by a forty-third supplemental indenture dated September 22, 2026.

Tenet Healthcare said it intends to use the net proceeds, after fees and expenses, combined with cash on hand, to redeem all $1.5 billion of its outstanding 5.125% senior secured first lien notes due November 2027

Form 8-K TENET HEALTHCARE CORP For: Sep 22

Tue, 22 Sep 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260922/27091082.html

Form 4 TENET HEALTHCARE CORP For: Sep 14 Filed by: KERREY J ROBERT

Wed, 16 Sep 2026 20:00:00 -0400

si-local-file:///var/storage/secattach/20260916/27071525.html

Form 4 TENET HEALTHCARE CORP For: Sep 10 Filed by: MARK RICHARD J

Mon, 14 Sep 2026 20:00:00 -0400

si-local-file:///var/storage/secattach/20260914/27059739.html

Form 144 TENET HEALTHCARE CORP Filed by: KERREY J ROBERT

Mon, 14 Sep 2026 14:28:00 -0400

si-local-file:///var/storage/secattach/20260914/27057899.html

Form 144 TENET HEALTHCARE CORP Filed by: MARK RICHARD J

Thu, 10 Sep 2026 15:58:00 -0400

si-local-file:///var/storage/secattach/20260910/27048232.html

Form 8-K TENET HEALTHCARE CORP For: Sep 08

Tue, 08 Sep 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260908/27037427.html

Tenet Healthcare prices $2B senior notes offering at 6.25%

Tue, 08 Sep 2026 17:00:28 -0400

Tenet Healthcare Corporation (NYSE: THC) has priced a private placement of $2.0 billion in senior notes due September 15, 2034, bearing interest at 6.250% per annum, according to a company statement.

The offering was upsized from an initially announced $1.5 billion. Completion is expected on September 22, 2026, subject to customary closing conditions.

Tenet said it intends to use the net proceeds, together with cash on hand, to redeem all $1.5 billion of its outstanding 5.125% senior secured first lien notes due November 2027, and to partially redeem $500 million of its 6.125% senior notes due October 2028.

The notes will be unsecured

Tenet Announces Upsizing and Pricing of Its $2.0 Billion Private Offering of Senior Notes

Tue, 08 Sep 2026 17:00:00 -0400

DALLAS--(BUSINESS WIRE)-- Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $2.0 billion in aggregate principal amount of senior notes due on September 15, 2034, which will bear interest at a rate of 6.250% per annum (the “notes”). The aggregate principal amount of notes to be issued in the offering was increased to $2.0 billion from the previously announced amount of $1.5 billion. Completion of the notes offering is expected to occur on September 22, 2026, and is subject to, among other things,

Tenet Announces Upsizing and Pricing of Its $2.0 Billion Private Offering of Senior Notes

Tue, 08 Sep 2026 17:00:00 -0400